The role of mTOR in depression and antidepressant responses

Life Sciences

Volumn 101, Issue 1-2, 2014, Pages 10-14

  Abelaira, Helena M ^a   Réus, Gislaine Z ^a,b   Neotti, Morgana V ^a   Quevedo, João ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Antidepressants; Depression; Ketamine; mTOR

Indexed keywords

ANTIDEPRESSANT AGENT; KETAMINE; MAMMALIAN TARGET OF RAPAMYCIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TRAMADOL;

COMPARATIVE STUDY; DEPRESSION; DRUG RESPONSE; HUMAN; MAJOR DEPRESSION; PREFRONTAL CORTEX; REVIEW; SIGNAL TRANSDUCTION;

MAMMALIA;

ANTIDEPRESSANTS; DEPRESSION; KETAMINE; MTOR;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; KETAMINE; MODELS, BIOLOGICAL; PREFRONTAL CORTEX; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84897582328     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.02.014     Document Type: Review

References (53)

1. I.M. Anderson Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a attenuates the effects of antidepressants on the forced swim test in rats Brain Res 709 1996 215 220
2. M.D. Antion, L. Hou, H. Wong, C.A. Hoeffer, and E. Klann mGluR-dependent long-term depression is associated with increased phosphorylation of S6 and synthesis of elongation factor 1A but remains expressed in S6K-deficient mice Mol Cell Biol 28 2008 2996 3007
3. M. Banasr, J.M. Dwyer, and R.S. Duman Cell atrophy and loss in depression: reversal by antidepressant treatment Curr Opin Cell Biol 23 2011 730 737
4. J. Barber Examining the use of tramadol hydrochloride as an antidepressant Exp Clin Psychopharmacol 19 2011 123 130
5. C. Beevers, F. Li, L. Liu, and S. Huang Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells Int J Cancer 119 2006 757 764
6. R.M. Berman, A. Cappiello, A. Anand, D.A. Oren, G.R. Heninger, and D.S. Charney et al. Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 4 2000 351 354
7. O. Berton, and E.J. Nestler New approaches to antidepressant drug discovery: beyond monoamines Nat Rev Neurosci 7 2006 137 151
8. M. Briley, and C. Moret Present and future anxiolytics IDrugs 3 2000 695 699
9. A. Chandran, A.H. Iyo, C.S. Jernigan, B. Legutko, M.C. Austin, and B. Karolewicz Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress Prog Neuropsychopharmacol Biol Psychiatry 40 2013 240 245
10. M. Cornu, V. Albert, and M.N. Hall mTOR in aging, metabolism, and cancer Curr Opin Genet Dev 23 1 2013 53 62
11. G.E. Correll, and G.E. Futter Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions Pain Med 7 1 2006 92 95
12. M.C. Denk, C. Rewerts, F. Holsboer, A. Erhardt-Lehmann, and C.W. Turck Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation Am J Psychiatry 68 1 2011 751 752
13. A. Deschwanden, B. Karolewicz, A.M. Feyissa, V. Treyer, S.M. Ametamey, and A. Johayem et al. Reduced metabotropic glutamate receptor 5 density in major depression determined by ABP688 PET and postmortem study Am J Psychiatry 168 2011 727 734
14. R.S. Duman, N. Li, R.J. Liu, V. Duric, and G. Aghajanian Signaling pathways underlying the rapid antidepressant actions of ketamine Neuropharmacology 62 2012 35 41
15. J.M. Dwyer, A.E. Lepack, and R.S. Duman mTOR activation is required for the antidepressant effects of mGluR2/3 blockade Int J Neuropsychopharmacol 15 2012 429 434
16. N.B. Farber, J.W. Newcomer, and J.W. Olney The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease Prog Brain Res 116 1998 421 437
17. A.M. Feyissa, A. Chandran, C.A. Stockmeier, and B. Karolewicz Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression Prog Neuropsychopharmacol Biol Psychiatry 33 2009 70 75
18. K. Hashimoto Emerging role of glutamate in the pathophysiology of major depressive disorder Brain Res Rev 6 2009 105 123
19. N. Hay, and N. Sonenberg Upstream and downstream of mTOR Genes Dev 18 2006 1926 1945
20. K. Hirota, and D.J. Lambert Ketamine: its mechanism(s) of action and unusual clinical uses Br J Anaesth 77 1996 441 444
21. C.A. Hoeffer, and E. Klann mTOR signaling: at the crossroads of plasticity, memory and disease Trends Neurosci 33 2010 67 75
22. J. Hunsberger, D.R. Austin, I.D. Henter, and G. Chen The neurotrophic and neuroprotective effects of psychotropic agents Dialogues Clin Neurosci 11 2009 333 348
23. E. Jacinto, R. Loewith, A. Schmidt, S. Lin, M.A. Ruegg, and A. Hall et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive Nat Cell Biol 6 2004 1122 1128
24. S.H. Jeon, Y. Kim, Y.S. Kim, Y. Lim, Y.H. Lee, and S.Y. Shin The tricyclic antidepressant imipramine induces autophagic cell death in U87MG gliom cells Biochem Biophys Res Commun 23 2011 311 317
25. T. Kaizuka, T. Hara, N. Oshiro, U. Kikkawa, K. Yonezawa, and K. Takehana et al. Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly J Biol Chem 28 2010 20109 20116
26. R.C. Kessler, and P.S. Wang The descriptive epidemiology of commonly occurring mental disorders in the United States Annu Rev Public Health 29 2008 115 129
27. D. Kim, D. Sarbassov, S. Ali, J. King, R. Latek, and H. Erdjument-Bromage et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery Cell 2002 163 175
28. D.H. Kim, D.D. Sarbassov, S.M. Ali, R.R. Latek, K.V. Guntur, H. Erdjument-Bromage, P. Tempst, and D.M. Sabatini GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR Mol Cell 11 2003 895 904
29. V. Krishnan, and E.J. Nestler The molecular neurobiology of depression Nature 455 2008 894 902
30. C. Lanni, S. Govoni, A. Lucchelli, and C. Boselli Depression and antidepressants: molecular and cellular aspects Cell Mol Life Sci 66 2009 2985 3008
31. M.H. Larsen, J.D. Mikkelsen, A. Hay-Schmidt, and C. Sandi Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment J Psychiatr Res 44 2010 808 816
32. E.C. Lauterbach Dextromethorphan as a potential rapid-acting antidepressant Med Hypotheses 76 2011 717 719
33. E.C. Lauterbach An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan Med Hypotheses 78 2012 693 702
34. N. Li, B. Lee, R.J. Liu, M. Banasr, J.M. Dwyer, and M. Iwata et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists Science 20 2010 959 964
35. N. Li, R.J. Liu, J.M. Dwyer, M. Banasr, B. Lee, and H. Son et al. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure Biol Psychiatry 69 2011 754 761
36. C.J. Lin, F. Robert, R. Sukarieh, S. Michnick, and J. Pelletier The antidepressant sertraline inhibits translation initiation by curtailing mammalian target of rapamycin signaling Cancer Res 15 2010 3199 3208
37. A.D. Lopez, and C.D. Mathers Measuring the global burden of disease and epidemiological transitions: 2002-2030 Ann Trop Med Parasitol 100 2006 481 499
38. R. Machado-Vieira, G. Salvadore, N. Diazgranados, and CA. Zarate Jr Ketamine and the next generation of antidepressants with a rapid onset of action Pharmacol Ther 123 2009 143 150
39. D. Martin, and D. Lodge Ketamine acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in vitro Neuropharmacology 24 1985 999 1003
40. D.P. McKernan, T.G. Dinan, and J.F. Cryan Killing the Blues: a role for cellular suicide (apoptosis) in depression and the antidepressant response? Prog Neurobiol 88 2009 246 263
41. R.S. Muddashetty, S. Kelić, C. Gross, and Bassel GJ Xu Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome J Neurosci 27 2007 5338 5348
42. C.B. Nemeroff, and M.J. Owens Treatment of mood disorders Nat Neurosci 5 2002 1068 1070
43. T.R. Peterson, M. Laplante, C.C. Thoreen, Y. Sancak, S.A. Kang, and W.M. Kuehl et al. DEPTOR is an mTOR inhibitor frequently over expressed in multiple myeloma cells and required for their survival Cell 137 2009 873 886
44. D. Sarbassov, S. Ali, D. Kim, D. Guertin, R. Latek, and H. Erdjument-Bromage et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton Curr Biol 14 2004 1296 1302
45. D. Sarbassov, D. Guertin, S. Ali, and D. Sabatini Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex Science 307 2005 1098 1101
46. L. Stephens, K. Anderson, D. Stokoe, H. Erdjument-Bromage, G. Painter, and A. Holmes et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B Science 279 1998 710 714
47. J.L. Warner-Schmidt, E.Y. Chen, X. Zhang, J.J. Marshall, A. Morozov, and P. Svenningsson et al. A role for p11 in the antidepressant action of brain-derived neurotrophic factor Biol Psychiatry 68 2010 528 535
48. B.L. Warren, S.D. Iñiguez, L.F. Alcantara, K.N. Wright, E.M. Parise, and S.K. Weakley et al. Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood related stimuli and disrupts ventral tegmental area gene expression in adulthood J Neurosci 31 2011 10347 10358
49. S. Wullschleger, R. Loewith, and M.N. Hall mTOR signaling in growth and metabolism Cell 124 2006 471 484
50. C. Yang, W.Y. Li, H.Y. Yu, Z.Q. Gao, X.L. Liu, and Z.Q. Zhou et al. Tramadol pretreatment enhances ketamine-induced antidepressant effects and increases mammalian target of rapamycin in rat hippocampus and prefrontal cortex J Biomed Biotechnol 2012 2012 175619
51. C. Yang, Z.Q. Zhou, Z.Q. Gao, J.Y. Shi, and J.J. Yang Acute increases in plasma Mammalian target of rapamycin, glycogen synthase kinase-3b, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients Biol Psychiatry 73 2013 e35 e36
52. J.J. Yu, Y. Zhang, Y. Wang, Z.Y. Wen, X.H. Liu, and J. Qin et al. Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway Psychopharmacology (Berl) 225 2 2013 361 372
53. R. Zoncu, A. Efeyan, and D.M. Sabatini mTOR: from growth signal integration to cancer, diabetes and ageing Nat Rev Mol Cell Biol 12 1 2011 21 35